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Abstract 
Efficient methodologies for the preparation of pentacyclo[5..4.0.02,6.03,10.05,9]
undecane (PCU) amine derivatives are described via microwave-assisted synthesis. 
The obtained results revealed that microwave-assisted synthetic procedures under 
controlled conditions (power, temperature and time) are very convenient, high 
yielding, efﬁcient and low-cost methods for the preparation of PCU amine 
derivatives. The new methods show several advantages including operational 
simplicity, good performance, signiﬁcant reduction in reaction time, less by-product 
formation and easier puriﬁcation. 
The synthesis, chemical and biological applications of saturated polycyclic hydrocarbon 
‘cage’ compounds have, in recent years, become an intense area of research interest. 
The pharmacology and medicinal potential of these compounds were realized with the 
discovery that the cage-like molecule, 1-amino-adamantane or amantadine (1, Fig. 1), an 
antiviral agent, could be used as a symptomatic treatment option for Parkinson’s disease 
patients.1,2 The pharmacological mechanism of amantadine as an anti-Parkinson’s
agent, at least in part, has generally been attributed to its ability to increase 
extracellular dopamine (DA) levels via reuptake inhibition and DA release.1,2 A
distinct structural similarity (Fig. 1) exists between amantadine (1) and the 
polycyclic pentacyclo[5.4.0.02,6.03,10.05,9]undecyl (PCU) amines 3 and 4.3,4 PCU
amines are derived from the Cookson’s diketone cage structure (2; 
pentacyclo[5.4.02,6.03,10.05,9]undecane-8,11-dione), which is obtained via the
intramolecular photocyclization of the Diels Alder adduct of p-benzoquinone and 
cyclopentadiene.5
The ﬁrst account of biological activity for PCU amines was published in 1986, detailing 
L-type calcium channel inhibition by 8-benzylamino-8,11-oxapentacycloundecane 
(NGP1-01, 8, Scheme 1).6 Early on in the synthesis of 8, it was ﬁrst assumed that the
aza-derivative 9 was formed. However, two independent studies based on X-ray 
crystallographic data later showed that when the imine 7 was reduced with sodium 
borohydride (NaBH4), the oxa-derivative 8 was formed, whereas reduction with sodium 
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cyanoborohydride (NaBH3CN) led to the aza-derivative 9.4,7 The PCU structures are 
now known to have a variety of pharmacological activities which include,  amongst  
others,  antiviral,3   anti-Parkinson’s,8–11   calcium and sodium channel 
antagonism,10–12 sigma receptor antagonism13–15 and nitric oxide synthase 
inhibition.16,17 These polycyclic structures have also been used as effective scaffolds 
with the ability to promote favourable pharmacokinetic and pharmacodynamic 
properties to conjugated privileged moieties.18 Based on the above and the number of 
publications describing the chemical and biological applications of these PCU-amines, 
we set out to improve on the current synthetic methods to increase the throughput of 
these drug-like molecules. 
 
The advantages of using microwave dielectric heating for performing organic 
reactions are well known, for example remarkable reduction of reaction time, 
improved yields, cleaner reactions and reduction or elimination of hazardous 
solvents compared to reactions performed under conventional thermal heating.19–21 
This Letter reports a new microwave-assisted synthesis of 
pentacyclo[5.4.0.02,6.03,10.05,9]undecane amines. We used two well known 
benzylamine derived PCUs (8 and 9)4,6,7 to develop the microwave-assisted methods 
(MWAMs) and compare them to methods reported in the literature. These methods 
could then be used in the development and synthesis of other distinct cage-derived 
molecules  and  to  improve  the  throughput  thereof.  The  experiments were performed 
under pressurized conditions in a closed vessel (unless otherwise speciﬁed) using a CEM 
Discover LabMate (model number 908010) with IntelliVent™ pressure control system 
and CEM Synergy™ software. The reported microwave conditions were optimized by 
varying the applied power, temperature and solvents used. 
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The conventional methods described in the literature4  for the synthesis of compounds 8 
and 9 (Scheme 1; steps i, iii, iv or vi) proceeded via the incorporation of benzylamine 
through amination, Dean–Stark dehydration and reductive amination using NaBH4 or 
NaCNBH3  to give the oxa-derivative, 8, and the aza-derivative, 9 in 36% and 42% yields, 
respectively. Comparing the above process to our newly developed MWAM, the yields of 
both 8 and 9 were signiﬁcantly improved to 71% and 69%, respectively, (Scheme 1; steps 
ii, v or vii). The main differences between the two methods were the aminative 
combination of 2 and 5 through MW irradiation and the omission of the Dean–Stark 
dehydration step. Bypassing the latter step avoided the use of the toxic solvent, benzene, 
contributing to a greener approach. In the MW combination step the reaction time was 
decreased from 30 to 10 min. Following analysis by thin-layer chromatography (TLC), it 
was found that in the MWAM, all the reagents were consumed within the speciﬁed time, 
unlike in the traditional method where the reagents were still present after extended 
reaction times. Increasing the reaction time to a maximum of 8 h did not increase 
consumption of the reactants in the conventional method; this was true when either 
EtOH or THF was used as the solvent. The Dean–Stark dehydration step (Scheme 1, step 
iii) was also found to be unnecessary in the synthesis of both 8 and 9 when anhydrous 
solvents were used in the conventional methods, and transannular cyclization still 
proceeded with yields in the  same  range  (37–43%)  as  speciﬁed  in the literature.4 The use 
of EtOH as the solvent in the MW reactions made it possible  to  set  up  this synthesis as a  
one-pot  process, which makes the process more convenient and efﬁcient. Also of interest 
was the fact that crystallization of amine 8 from the MW reaction proceeded without the 
need for prior puriﬁcation through column chromatography, as was the case for 8 
prepared via the conventional  reaction. 
 
An alternative method for the synthesis of the aza-PCU compound (9), as described by 
Kassiou et al. in 1996,15 was also used and optimized through MWAMs (Scheme 2). This 
required the synthesis of the ketal-derivative 10 of PCU (Scheme 2, step i or ii). The ketal was 
synthesized by reacting 2 and ethylene glycol under Dean–Stark dehydration conditions 
using toluene to produce 10. Using the MWAM we achieved a 12-fold reduction in reaction 
time compared to the conventional reaction, and also increased the yield of 10 from 
88% to 95% (Table 1). In the conventional method, ketal 10 is reacted with benzylamine by 
amination in a sealed tube at 100 °C to yield the ketal-imine PCU (11), which was 
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subsequently reduced using NaBH4 and the ﬁnal aza-PCU (9) was obtained in 29% yield 
through transannular cyclization using 3 M HCl/acetone (Scheme 2, Steps iii and v–vi). 
The requirement for more extreme conditions suggests that the ketal group has an effect, 
either steric or electronic, on the adjacent carbonyl making nucleophilic attack more 
difﬁcult. For these reasons we set out to optimize the process at the aminative conjugation  
step  where MW irradiation could be used (Scheme 2, step iv). The reaction conditions  
were  maintained  at  100 °C,  150 W  and  150 psi  for 30 min to produce the imine 11 (TLC 
analysis indicated completion of the reaction). 
 
 
 
 
 
A 36-fold reduction in reaction time was achieved for this step and following the same 
procedure as described above (Scheme 2, steps v–vi), we were able to synthesize azaCU 
9 in 58% yield, which represents a doubling of the yield compared to the conventional 
method (Table 1). 
 
We further developed an alternative synthetic route for the synthesis of oxa-PCUs (Scheme 
2, steps vii–viii). Compound 8 was synthesized by reacting 5 with 10 using the MWAM as 
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described for 9 to produce the imine-ketal PCU (11). This imine-ketal PCU was 
hydrolysed using a 6% HCl(aq) solution to yield 7. Further reduction using NaBH4 yielded 
the oxa-PCU (8) in 21% yield. Although the yield was poor, this new method represents 
a valuable addition to the array of synthetic routes available to synthesize oxa-PCUs and 
might be of speciﬁc value for regiospeciﬁc synthesis, and where highly reactive 
reagents are used and reaction at both ketone moieties of the diketone-PCU (2) is 
unavoidable. With protection of one carbonyl group by means of a ketal-moiety it should 
be possible to produce a mono-substituted oxa-PCU compound. 
 
It should also be noted that the MWAMs required smaller volumes or completely 
omitted the use of toxic solvents compared to the conventional methods, thus 
contributing to green chemistry. The compounds produced through the MWAMs were of 
a higher purity compared to the conventional methods, therefore the puriﬁcation 
procedures required less solvents and consumables. Ethanol was also used in the 
majority of the reaction steps in the MWAMs, which is less toxic and less hazardous 
than the solvents used in the conventional methods. 
 
The newly developed MWAMs were further used to demonstrate the relevance and 
advantages thereof to synthesize a novel PCU amine (compound 20, Scheme 3).28 The 
synthesis commenced from a series of microwave-assisted SN2 reactions to produce the 
intermediate 2-(4-benzylpiperazin-1-yl)ethanamine (17) in 92% yield. Compound 17 
was reacted with the ketal-PCU (10) through the same MWAM developed for compound 
11. The reaction conditions were maintained at 100 °C, 150 W and 150 psi for 30 min to 
produce the imine (18) on completion of the reaction (as per TLC analysis). The 
subsequent reaction steps were the same as for compound 9 and yielded the ﬁnal 
compound, N-[2-(4-benzylpiperazin-1-yl)ethyl]-4-azahexacyclo 
[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ol (20) in 53% yield. The yield, as is the case 
for all the synthetic routes described, was calculated from the amount of diketonePCU 
(2) used. The reaction time required for the whole sequence using the MWAM was 14.5 
h. The synthetic sequence described for compound  20 was  also performed using the 
conventional method of thermal heating. Compound 20 was successfully synthesized 
using this approach, but the sequence required more than 100 h for completion and 
yielded only 10% of the ﬁnal compound. 
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A sevenfold reduction in reaction time was thus achieved using the MWAM and the yield 
was improved signiﬁcantly. Novel compound 20 was shown to be a potent sigma-1 
receptor inhibitor (IC50  = 0.139 lM, Ki  = 67.26 nM), and preliminary studies have 
indicated that it has some degree of N-methyl-D-aspartate receptor and voltage-
dependent calcium channel inhibitory activity. Compound 20 may thus ﬁnd application as 
a potential neuro-active drug by modulating certain neuroprotective targets for a number of 
neurological disorders. This one example serves as an illustration of how MWAM can be 
used to reduce reaction times, improve yields and increase the throughput of PCU-
derivatives, which might serve as potential drugs. 
 
These new MWAMs can be utilized to optimize the reaction conditions and improve on 
the synthesis of PCU derived molecules with high efﬁciency and throughput. In addition, 
the microwave process, when compared with the conventional methods, has several 
advantages, viz: reduction of the reaction time, less by-product formation and easier 
puriﬁcation. Based on the above and on the number of research groups currently 
studying the chemistry and biology of polycyclic cage moieties, these MWAMs should 
contribute to the synthetic approaches towards cage-derived organic compounds and 
should aid in the design and discovery of new PCU derivatives. 
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after which the solvents were removed in vacuo, the residue suspended in H2O 
(20 mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic 
fractions were washed with H2O (2 x 20 mL), dried (MgSO4) and evaporated 
in vacuo to yield a light-yellow oil. Crystallization from EtOH rendered the ﬁnal 
product 8 as a colourless microcrystalline solid (yield: 0.852 g, 3.21 mmol, 71%, 
mp: 70–71 °C). The physical characteristics of this compound were exactly the 
same as those described in the literature.4,7 
23. Synthesis  of  8 via  the  ketal  derivative  10 of  PCU:  A mixture of 10 
(1.0 g, 4.59 mmol)  and  benzylamine  (5,  0.49 g,  4.59 mmol)  in  EtOH  (5 
mL)  was transferred to a sealed microwave vessel (10 mL capacity). The 
mixture was placed in a CEM Discover Labmate microwave reactor and 
irradiated for 30 min at 150 W, 100 °C, and 100 psi. The solution was cooled 
and 6% HCl(aq) solution (20 mL) was added gradually and the mixture stirred 
at room temperature for 3.5 h. The solvents were removed in vacuo, the 
residue produced was suspended in H2O (20 mL), made basic with 1 M 
NaOH solution and extracted with CH2Cl2 (3 x 20 mL). The combined 
organic fractions  were dried (MgSO4) and evaporated in vacuo to yield a 
light-yellow oil. The oil was dissolved in EtOH (10 mL) and NaBH4 (0.4 g, 
10.56 mmol) was added portionwise in excess. This mixture was stirred at 
room temperature for 8 h after which the solvents were removed in vacuo. The 
residue was suspended in H2O (20 mL) and extracted with CH2Cl2 (3 x 20 
mL). The combined organic fractions were washed with H2O (2 x 20 mL), 
dried (MgSO4) and evaporated in vacuo to yield a light-yellow oil. 
Puriﬁcation was carried out using ﬂash column chromatography with the 
solvent system; hexane: CH2Cl2 (1:1) to obtain the product as a white solid. 
Crystallization from EtOH rendered the ﬁnal product 8 as a colourless 
microcrystalline solid (yield: 0.255 g, 0.96 mmol, 21%,  mp:  70–71 °C).  The  
physical  characteristics  of  this  compound  were exactly the same as those 
described in the literature.4,7  
24. Synthesis    of    9:    Pentacyclo[5.4.02,6.03,10.05,9]undecane-8,11-dione   (2,   
1 g, mmol) and benzylamine (5, 0.49 g, 4.59 mmol) were dissolved in EtOH 
(5 mL) and transferred to a sealed microwave vessel (10 mL capacity). The 
mixture was placed in a CEM Discover Labmate microwave reactor and 
irradiated for 10 min at 100 W, 80 °C, and 100 psi. The mixture was removed 
from the microwave reactor and EtOH (20 mL), AcOH (1.5 mL) and NaBH3CN 
(0.66 g, 10.56 mmol)  were  added. This mixture  was stirred at room 
temperature for 2 h after which  it  was  concentrated  in  vacuo,  and  H2O 
(20 mL) was added to the residue. The resulting suspension was stirred, and 
solid sodium bicarbonate was added portionwise until evolution of carbon 
dioxide ceased. Excess solid sodium bicarbonate (0.4 g) was added and the 
aqueous suspension was extracted with CH2Cl2 (4 x 20 mL). The combined 
extracts were washed with H2O (2 x 100 mL), dried over MgSO4, ﬁltered, and 
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concentrated in vacuo. A yellow microcrystalline solid was thereby obtained. 
This material was recrystallized from isopropanol to afford compound 9 (yield: 
0.838 g, 3.16 mmol, 69%, mp: 158 °C) as a colourless microcrystalline solid. 
The physical characteristics of this compound were exactly the same as 
those described in the literature.4,7 
25. Synthesis  of  9 via  the  ketal  derivative  10 of  PCU:  A mixture of 10 
(1.0 g, 4.59 mmol) and benzylamine (0.49 g, 4.59 mmol) in EtOH (5 mL) 
was transferred to a sealed microwave vessel (10 mL capacity). The mixture 
was placed in a CEM Discover Labmate microwave reactor and irradiated for 30 
min at  150 W,  100 °C,  and  150 psi.  The  solution  was  cooled,  NaBH4   
(0.35 g, 9.17 mmol)  was  added  gradually  and  the  mixture  was  stirred  at  
room temperature for 8 h. The solution was concentrated in vacuo, H2O (20 
mL) was added and the solution was extracted with CH2Cl2 (3 x 15 mL). 
The combined organic layers were washed with brine (15 mL), dried (MgSO4) 
and concentrated in vacuo. To the crude residue was added acetone (25 mL) 
and aqueous 4 M HCl (15 mL) with stirring at room temperature for 12 h. H2O 
was added (250 mL) and the solution was basiﬁed to pH 14 with aqueous 1 
M NaOH and extracted with CH2Cl2 (3 x 25 mL). The combined organic 
extract was dried over MgSO4 and concentrated to give the crude residue, 
which was recrystallized from isopropanol to yield the desired product 9 
(yield: 0.708 g, 2.67 mmol, 58%, mp: 71 °C). The physical characteristics of 
this compound were exactly the same as those described in the literature.4,7 
26. Banister, S. D.; Moussa, I. A.; Jordan, M. J. T.; Coster, M. J.; Kassiou, M. Bioorg. 
Med.  Chem.  Lett.  2010, 20, 145.  
27. Synthesis      of      10:      Pentacyclo[5.4.02,6.03,10.05,9]undecane-8,11-dione    
(1 g, 4.59 mmol), ethylene glycol (0.45 mL) and p-TsOH (0.04 g, 1.9 mmol) were 
dissolved in toluene (15 mL) and placed in a CEM Discover Labmate microwave 
reactor set to the open vessel function and reﬂuxed using a Dean–Stark 
apparatus for 30 min at 100 W and 110 °C. The reaction was allowed to cool 
followed by addition of an aqueous solution of 10% (m/v) Na2CO3 (20 mL) and 
extracted with CH2Cl2 (3 x 20 mL). The organic layer was  dried  using 
anhydrous Na2SO4, ﬁltered and the solvent evaporated in vacuo. The crude 
residue was puriﬁed via recrystallization from hexane to afford 10 as a white 
microcrystalline solid (yield: 0.951 g, 4.36 mmol, 95%, mp: 71 °C). The physical 
characteristics of this compound were exactly the same as those described in 
the literature.26   
28. Synthesis of 20: Step 1: Benzyl chloride (1 g, 7.96 mmol) was added to a 
stirred suspension of piperazine (3.42 g, 39.8 mmol) and K2CO3 (1.32 g, 9.56 
mmol) in CH3CN (3 mL). The mixture was transferred to a sealed 
microwave vessel (10 mL capacity) and placed in a CEM Discover Labmate 
microwave reactor and allowed to react for 5 min at 150 W, 100 °C and 100 
psi. The CH3CN was removed in vacuo and CH2Cl2 (20 mL) was added. 
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The crude product was washed with H2O (5 x 20 mL). The organic layer was 
dried (MgSO4), ﬁltered and evaporated in vacuo to yield the desired 
compound, 2-(piperazin-1-yl)ethanamine (15), as a viscous yellow oil (1.319 
g, 7.48 mmol, 94%). The physical characteristics  of compound 15 were 
exactly  the same as those described in the literature. 29 Step 2: 2-
bromoethanamine (0.192 g, 1.55 mmol) was added to a suspension of 15 
(1.30 g, 7.38 mmol) and K2CO3  (0.257 g, 1.86 mmol) in CH3CN (5 mL). The 
reaction was placed in the microwave reactor and allowed to react for 10 min at 
150 W, 100 °C and 100 psi. The mixture was concentrated in  vacuo,  added  to  
CHCl3  (20 mL)  and  washed  with  H2O (3 x 25 mL). The organic solution 
was dried over MgSO4, ﬁltered and evaporated in vacuo to afford the 
desired product, 2-(4-benzylpiperazin-1-yl)ethanamine (17), as a clear oil with 
low vis osity (0.312 g, 1.55 mmol, 92%). Physical data: 1H NMR (200 MHz, 
CDCl3): dH:15,16), 3.72 (s, 2H, H-10), 2.78 (t, J = 6.7 Hz, 2H, H-7), 2.48 (s, 
4H, H-3, 5), 1.86 (t,   J = 6.7 Hz,   2H,   H-8),   1.24   (s,   4H,   H-2,   6).   
Step   3:   pentacyclo [5.4.0.02,6.03,10.05,9.08,11]undecane-8,11-dione 
ethylene acetal (10, 200 mg, 0.917 mmol)    and    2-(4-benzylpiperazin-1-
yl)ethanamine    (17,    200 mg, 0.913 mmol) were reacted under microwave 
conditions. The reactants were dissolved in EtOH (5 mL) at a maximum 
temperature of 100 °C, power setting of 150 W and pressure of 150 psi for 30 
min. The mixture was allowed to cool and  used  directly  in  the  next  step.  
The  cooled   solution  of  N-[2-(4-benzylpiperazin-1-yl)ethyl]-4-
pentacyclo[5.4.0.02,6.03,10.05,9]undecane-11-ethylene acetal  (18)  was 
dissolved  in  EtOH (5 mL) and NaBH4   (159 mg, 4.20 mmol) was added. The 
mixture was stirred at room temperature for 8 h after which the EtOH was 
evaporated under reduced pressure. H2O (10 mL) was added and the 
mixture was  extracted with CH2Cl2 (3 x 10 mL).  The combined organic 
extracts were washed with brine (10 mL) and concentrated in vacuo. To this 
crude material, acetone (25 mL) and 4 M aq HCl (15 mL) were added. After 
stirring at room temperature for 6 h, the mixture was diluted with H2O (200 
mL), basiﬁed to pH 14 with 1 M aq NaOH, and extracted with CH2Cl2 (3 x 15 
mL). The combined organic extracts were dried (Na2SO4) and concentrated 
in vacuo. The crude product was puriﬁed by recrystallization from EtOH to 
yield the desired compound 20 as colourless crystals (Yield: 0.183 mg, 0.485 
mmol, 53%). Physical data: 1H NMR (200 MHz, CDCl3) dH: 7.26–7.16 (m, 
5H, H-23, 24, 25, 26, 27), 3.43 (s, 2H, H-21), 3.43 (t, J = 4.7 Hz, 2H, H-13), 
2.96–2.30 (m, 19H, H-1, 2, 3, 4, 5, 6, 7,8, 9, 10, 11, 14, 16, 17, 19, 20), 1.76:1.44 
(AB-q, JAB = 10.4 Hz, 2H, H-4a, 4b). 13C NMR (50 MHz, CDCl3) dc: 137.98, 
129.12, 128.21, 127.05, 70.79, 62.75, 58.66, 56.90, 52.75, 53.42, 51.53, 46.62, 
45.68, 45.40, 43.32, 43.25, 42.15, 41.88, 41.69. IR (tmax): 3243, 2950, 2813, 
1320, 1284 cm-1. HR-MS (ESI, 15 eV): 378.2546 (M+H+). 
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